Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.31
(-16.67%)
USD 0.31
(-16.67%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.89 Million USD | 94.32% |
| 2022 | 975.67 Thousand USD | -57.2% |
| 2021 | 2.27 Million USD | 2.03% |
| 2020 | 2.23 Million USD | 0.0% |
| 2018 | 593.81 Thousand USD | 46.39% |
| 2017 | 405.64 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.01 Million USD | 0.96% |
| 2024 Q1 | 1.99 Million USD | 5.09% |
| 2023 Q1 | 3.53 Million USD | 261.81% |
| 2023 Q3 | 1.76 Million USD | -7.12% |
| 2023 FY | 1.89 Million USD | 94.32% |
| 2023 Q4 | 1.89 Million USD | 7.36% |
| 2023 Q2 | 1.9 Million USD | -46.13% |
| 2022 Q4 | 975.67 Thousand USD | -0.15% |
| 2022 FY | 975.67 Thousand USD | -57.2% |
| 2022 Q2 | 2.47 Million USD | 3.23% |
| 2022 Q1 | 2.4 Million USD | 5.36% |
| 2022 Q3 | 977.14 Thousand USD | -60.59% |
| 2021 FY | 2.27 Million USD | 2.03% |
| 2021 Q4 | 2.27 Million USD | 0.0% |
| 2020 FY | 2.23 Million USD | 0.0% |
| 2018 FY | 593.81 Thousand USD | 46.39% |
| 2017 FY | 405.64 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | 99.8% |
| Embecta Corp. | 2.03 Billion USD | 99.907% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | 99.598% |
| Dynavax Technologies Corporation | 375.02 Million USD | 99.494% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | 99.713% |
| Pacira BioSciences, Inc. | 704.25 Million USD | 99.731% |
| PainReform Ltd. | 2.69 Million USD | 29.544% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | 98.843% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | 69.119% |
| SCYNEXIS, Inc. | 55.45 Million USD | 96.581% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | 79.384% |
| Cosmos Health Inc. | 30.25 Million USD | 93.733% |
| Journey Medical Corporation | 56.49 Million USD | 96.644% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | 69.119% |
| Safety Shot Inc | 3.89 Million USD | 51.286% |
| Alpha Teknova, Inc. | 38.55 Million USD | 95.082% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | 98.615% |
| Bright Green Corporation | 6.43 Million USD | 70.551% |
| Procaps Group, S.A. | 462.06 Million USD | 99.59% |
| Theratechnologies Inc. | 98.63 Million USD | 98.078% |
| Harrow Health, Inc. | 241.75 Million USD | 99.216% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | 78.347% |
| Biofrontera Inc. | 23.13 Million USD | 91.806% |
| DURECT Corporation | 30.4 Million USD | 93.765% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | 99.611% |
| Cronos Group Inc. | 43.73 Million USD | 95.665% |
| OptiNose, Inc. | 194.33 Million USD | 99.024% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | 99.768% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | 96.086% |
| RedHill Biopharma Ltd. | 20.97 Million USD | 90.962% |
| Organogenesis Holdings Inc. | 181.36 Million USD | 98.955% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | 49.738% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | 96.39% |
| Radius Health, Inc. | 804.29 Million USD | 99.764% |
| Universe Pharmaceuticals INC | 13.75 Million USD | 86.216% |
| ProPhase Labs, Inc. | 42.54 Million USD | 95.544% |
| Phibro Animal Health Corporation | 725.54 Million USD | 99.739% |
| Procaps Group S.A. | 462.06 Million USD | 99.59% |
| Alvotech | 1.88 Billion USD | 99.899% |
| TherapeuticsMD, Inc. | 14.02 Million USD | 86.479% |
| Viatris Inc. | 27.21 Billion USD | 99.993% |
| Rockwell Medical, Inc. | 30.88 Million USD | 93.861% |
| Aytu BioPharma, Inc. | 90.37 Million USD | 97.902% |
| SIGA Technologies, Inc. | 57.97 Million USD | 96.73% |
| Tilray Brands, Inc. | 892.11 Million USD | 99.787% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | 99.137% |
| Shineco, Inc. | 47.6 Million USD | 96.017% |
| PetIQ, Inc. | 645.22 Million USD | 99.706% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -763.718% |
| Incannex Healthcare Limited | 5.83 Million USD | 67.479% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | 99.814% |
| Alimera Sciences, Inc. | 107.35 Million USD | 98.234% |
| Silver Spike Investment Corp. | 3 Million USD | 37.008% |
| Assertio Holdings, Inc. | 148.41 Million USD | 98.723% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | 91.105% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | 73.015% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | 77.67% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | 98.907% |
| Hempacco Co., Inc. | 18.82 Million USD | 89.927% |
| Talphera, Inc. | 6.29 Million USD | 69.857% |
| Alvotech | 1.88 Billion USD | 99.899% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | 98.902% |
| Lantheus Holdings, Inc. | 835.25 Million USD | 99.773% |
| Currenc Group, Inc. | 177.67 Million USD | 98.933% |
| Kamada Ltd. | 109.96 Million USD | 98.276% |
| Indivior PLC | 1.95 Billion USD | 99.903% |
| Evoke Pharma, Inc. | 9.64 Million USD | 80.349% |
| Flora Growth Corp. | 17.22 Million USD | 88.991% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | 77.67% |
| Evolus, Inc. | 209.68 Million USD | 99.096% |
| HUTCHMED (China) Limited | 536.38 Million USD | 99.647% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | 99.783% |
| Akanda Corp. | 12.66 Million USD | 85.034% |